Food and Drug Administration Has Extended the Review Timeline for the Ipilimumab Biologics License Application Melanoma..Jim Breitfeller

FDA Has Pushed backed the Review Timeline for the Ipilimumab Biologics License Application to March 26, 2011. How many Melanoma Patients need to die before Ipi is FDA approved? Who do we blame, BMS or the FDA. Someone should be held accountable.

Food and Drug Administration Has Extended the Review Timeline for the Ipilimumab Biologics License Application






“It is not the strongest of the species that survives, nor the most intelligent, but the one most responsive to change.”
~Charles Darwin~
Take Care,
Jimmy B